| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.5 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.042 | 0.5 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.09 | 0.5 |